Cidara Therapeutics Announces First Participants Dosed in Phase 3 ANCHOR Trial Evaluating CD388 for the Prevention of Seasonal Influenza in High-Risk Populations

Phase 3 study expected to enroll 6,000 participants starting in the Northern Hemisphere - Participants will include adults ...

Cidara Therapeutics Announces Expanded and Accelerated Phase 3 Plan for CD388, a Non-Vaccine Preventative of Seasonal Influenza

Update based on FDA End-of- Phase 2 meeting outcome - Phase 3 study start accelerated by six months, in time for the fall ...

Solar Eclipse this weekend: Best locations to watch the September celestial display across the globe | Date and time

Stargazers are set for a remarkable spectacle this weekend, as the Southern Hemisphere readies for the year’s second and ...